Denver and Cherry Hills, Colorado
Exosome supply and 503A pharmacy access for Denver and Cherry Hills practices
ExaVeyra supplies research-use exosome material to licensed practices in Denver and Cherry Hills Village from its base in Miami Beach, and because Colorado is a state where the 503A pharmacy partner holds a non-resident license, a prescriber here can also send an individual prescription for a compounded preparation to that pharmacy, which dispenses it directly. This page covers what a practice in Denver County and the Arapahoe County suburbs can source, how cold-chain material arrives, and where the Colorado law questions are answered.
It speaks to the practice, names no condition or use, and leaves delegation and statute to the Colorado sourcing guide.
What a Denver and Cherry Hills practice can source
| Material | Availability here |
|---|---|
| Exosome material | Available. Research-use exosome formats, characterised per lot, shipped cold-chain from Miami Beach to licensed practices in every state and Puerto Rico. |
| Compounded 503A preparations | Available. Prepared to an individual prescription by our 503A pharmacy partner, which holds a non-resident pharmacy license for Colorado, and dispensed by that pharmacy to the patient named on the prescription. |
| Documentation | A lot-specific certificate of analysis is available on request for every exosome lot; compounded preparations carry the pharmacy label and beyond-use date. |
The practice landscape in Denver and Cherry Hills
Denver anchors the medical market of the Front Range, and its academic anchor is the Anschutz Medical Campus in Aurora, where the University of Colorado School of Medicine sits alongside UCHealth University of Colorado Hospital and Children's Hospital Colorado. Inside the city, Rose Medical Center on East Ninth Avenue, Saint Joseph Hospital and Presbyterian/St. Luke's in Uptown, National Jewish Health, Denver Health downtown and AdventHealth Porter on South Downing Street each carry a ring of medical office buildings. To the south, Swedish Medical Center in Englewood and Sky Ridge Medical Center in Lone Tree anchor the Arapahoe and Douglas County suburbs, and the former University of Colorado Health Sciences Center site at Ninth Avenue and Colorado Boulevard has been redeveloped with clinical space among housing and retail. Lutheran Medical Center in Wheat Ridge and Saint Anthony Hospital in Lakewood complete the ring on the west side, and specialist referral traffic moves around the metro on the beltway rather than through the centre.
Cherry Hills Village is residential by design, with no commercial development inside its boundary, so the practices that serve its residents sit just outside it. Dermatology, plastic surgery, aesthetic and concierge practices occupy the mixed-use blocks of Cherry Creek North between First and Third Avenues around the UCHealth Cherry Creek medical building, more sit along University Boulevard and Hampden Avenue in Englewood and Greenwood Village, and the Denver Tech Center office parks along Interstate 25 at Belleview and Orchard hold hormone-optimization, longevity and functional medicine practices leasing suites among the corporate tenants. Practice organisation runs the full range, from hospital-affiliated groups with a dozen sites to single-physician aesthetic offices in Cherry Creek, and the patient base is year-round and active rather than seasonal, with a large share of residents in their working years. Boulder to the northwest and Highlands Ranch and Castle Rock to the south carry their own practice clusters on the same Front Range lane.
A Denver delivery address is a Cherry Creek suite in a mixed-use building with a street door or an upstairs office reached through a shared lobby, a Tech Center tower with a loading dock and a security desk, or a suburban medical plaza with its own entrance, and a practice never has a delivery address inside Cherry Hills Village itself. The carrier air gateway is Denver International Airport on the plains east of the city, and the ground leg from the airport into the metro crosses no mountain road, so a shipment to Cherry Creek or the Tech Center is untouched by the closures that reach the Interstate 70 corridor west of the city. A practice in the foothills, in Evergreen or Genesee, is on the mountain side of that line and reads the Colorado guide for the transit range. Peña Boulevard and Interstate 70 carry the airport traffic into the city, and the ground leg to a Tech Center address follows Interstate 225 and Interstate 25 around the east side of the metro rather than through downtown.
Altitude and weather add two local receiving notes. The city sits a mile above sea level with a dry climate and strong winter sun, so a package left on a sunlit step in January can warm even when the air is cold, and the receiving procedure asks for the package to move indoors and into storage at once. The heaviest snow on the Front Range falls in March and April rather than in midwinter, and a spring storm that closes Interstate 25 or slows the airport pushes deliveries back, so dispatch in those months is checked against the forecast and a Friday dispatch is avoided when a weekend hold at the carrier hub is possible. Hail in late spring and early summer is the other Front Range hazard, and a package left under an awning fares better than one on an open step, a small detail the receiving instruction on the account can record. The metro also empties toward the mountains on Friday afternoons and refills on Sunday evenings through the ski season, and a practice desk that closes early on a winter Friday should say so on the account.
The hair and scalp literature, for Denver and Cherry Hills practices
The hair and scalp series on this site sets out, component by component, what the peer-reviewed literature and the FDA say about each formulation class the literature discusses. What follows is what that means for sourcing in this market.
The hair and scalp series on this site is the evidence reference for each formulation class the literature discusses, and for a Denver practice the sourcing position is that research-use exosome formats are supplied on the practice's verified account, and the compounded preparations the pharmacy partner prepares are dispensed by that pharmacy against individual prescriptions, so the two travel separately under their own regimes. For each component the evidence pages set out the literature and the FDA communications, and the product category lists what the pharmacy partner prepares to prescription.
Denver groups with sites in Cherry Creek, the Tech Center and Lone Tree tend to read that as a question of which board answers what: the Colorado Medical Board under the Division of Professions and Occupations governs the prescriber and what a prescriber may delegate, the Colorado State Board of Pharmacy governs the dispensing pharmacy and its non-resident license, and the practice account governs which site receives which lot of research-use material. The Colorado sourcing guide sets those three out in order. A group whose Lone Tree site sits in Douglas County and whose Cherry Creek site sits in Denver County answers to the same state boards for both, since Colorado licenses at the state level, and the county line changes nothing about the account.
How material reaches Denver and Cherry Hills
Cold-chain shipments dispatch from the Miami Beach facility under continuous temperature monitoring and reach Colorado practices in 1 to 3 business days, scheduled to avoid a weekend hold at the carrier hub.
Colorado law is a separate question, answered in the state guide
What a Colorado practice may offer, who in the practice may handle material, whether the state has a stem cell or regenerative-medicine statute and how any such statute reads against an acellular preparation, and which boards verify a license are covered in the Colorado sourcing guide rather than repeated here. Nothing about the city changes any of it.
Denver and Cherry Hills sourcing questions
- How does research-use exosome material reach a Denver or Cherry Creek address?
- Shipments leave Miami Beach under validated temperature monitoring and route through the carrier air network into Denver International Airport, then by ground across the plains to the address on file. The Colorado guide states the transit range, and a Cherry Creek or Tech Center address involves no mountain road, so winter closures on the Interstate 70 corridor west of the city do not reach it.
- Can a Denver practice source both exosome material and compounded preparations?
- Yes. Colorado is a state where the 503A pharmacy partner holds a non-resident pharmacy license, so a prescriber in Denver can send an individual prescription for a compounded preparation to that pharmacy, which dispenses it directly, and research-use exosome material ships to any licensed practice. Separate regimes govern the two, which never share a shipment or a stocking calendar.
- Does altitude change how a Denver practice receives frozen material?
- The receiving steps are the same as at sea level: read the temperature indicator, log the arrival time and package condition, and move the material to its storage temperature at once. A frozen format is unaffected by altitude, while the dry air and strong sun at a mile of elevation can warm a package left outdoors faster than the winter air suggests, so a named staff member receives it indoors.
Sources
- Colorado Division of Professions and Occupations, Medical Board (accessed 17 September 2026)
- Colorado Division of Professions and Occupations, Board of Pharmacy (accessed 17 September 2026)
- Colorado Department of Public Health and Environment (accessed 17 September 2026)
Last reviewed 17 September 2026 by Benn Bluestein-Veyra, M.Sc. Organic Chemistry. Availability is read from the state registry at the time of the request.
These statements have not been evaluated by the FDA. Products are not intended to diagnose, treat, cure, or prevent any disease. There are no FDA-approved exosome products. Exosome material distributed by ExaVeyra Sciences is supplied for Research Use Only, for medical, molecular biology, and biochemistry research applications, and ExaVeyra Sciences makes no statement about administration, route, or outcome. Compounded medications are a separate product class: they are not FDA-approved finished drug products, they are prepared under section 503A of the Federal Food, Drug, and Cosmetic Act against a prescription for an individual patient, and they are prescription products rather than research-use-only material. ExaVeyra does not supply controlled substances. This page is provided for informational purposes only. It is not medical advice, it is not intended to diagnose, treat, cure, or prevent any disease, and it is not a substitute for the judgment of a licensed practitioner. Consult a healthcare professional before acting on anything stated here. The FDA has not approved GHK-Cu or any exosome product for hair loss or any form of alopecia. Compounded medications are not FDA-approved; they are prepared by a licensed 503A compounding pharmacy for an individual patient against that patient’s prescription, and they are supplied to NPI-verified licensed practitioners only. Where this page discusses an FDA-approved active such as oral finasteride or topical minoxidil, the approved product’s labeling governs and nothing here modifies it. ExaVeyra Sciences is a supplier and takes no part in any diagnosis, treatment decision, or plan of care. ExaVeyra Sciences does not supply controlled substances. Findings described on this page are attributed to the peer-reviewed literature and to the agencies cited, and a citation establishes that a question was studied, not that any product is suitable for a given patient. The content of these guides is provided for general informational purposes only. It does not constitute legal, medical, or regulatory advice, and does not establish that any particular product or practice is compliant. Regulatory requirements vary by state and depend on the circumstances of each practice. Each practitioner should consult their own legal counsel and the applicable state licensing boards before acting on anything stated here. Exosome material is supplied for Research Use Only. No exosome product is FDA-approved for any use, and ExaVeyra Sciences makes no statement about administration, route, or outcome.
Reference only. Not legal or medical advice.
The content of these guides is provided for general informational purposes only. It does not constitute legal, medical, or regulatory advice, and does not establish that any particular product or practice is compliant. Regulatory requirements vary by state and depend on the circumstances of each practice. Each practitioner should consult their own legal counsel and the applicable state licensing boards before acting on anything stated here.
Read the full disclaimer
ExaVeyra Sciences publishes these guides as a reference for licensed practitioners. They summarize publicly available federal and state requirements as those requirements read on the review date shown above. The content is provided for general informational purposes only and does not constitute legal, medical, or regulatory advice, and it does not establish that any particular product or practice is compliant.
No attorney-client relationship, and no professional or clinical relationship of any kind, is created by accessing these materials. ExaVeyra Sciences is a supplier of research-use materials. It is not a law firm, it is not a regulatory consultant, and it takes no part in any diagnosis, treatment decision, or plan of care. Each practitioner is responsible for retaining their own legal counsel and for determining, with that counsel and the applicable state licensing boards, how the requirements described here apply to the services, staffing, and structure of their own practice.
Statutes, regulations, board rules, and agency positions are subject to amendment, supersession, and reinterpretation. ExaVeyra Sciences makes no representation or warranty as to the accuracy, completeness, timeliness, or applicability of this content to any particular practice. Citations and links to third-party sources are provided for convenience only and do not constitute an endorsement of their content.
The practitioner and the practice are solely responsible for compliance with all applicable licensing, scope of practice, supervision, ownership, facility, recordkeeping, and tax requirements, and for all clinical decisions, including the suitability of any material for a given patient. To the fullest extent permitted by law, ExaVeyra Sciences disclaims all liability for any action taken or not taken in reliance on this content.